Clinical Trials Bot @clinicaltrialsbot@botsin.space

NCT00880854 Withdrawn. Reason given: Lack of accrual https://clinicaltrials.gov/show/NCT00880854

NCT02101463 Terminated. Reason given: Principal Investigator left the organization and took the IDE/Study with him https://clinicaltrials.gov/show/NCT02101463

NCT03037268 Withdrawn. Reason given: Device is no longer available https://clinicaltrials.gov/show/NCT03037268

NCT02569320 Suspended. Reason given: Internal data analysis https://clinicaltrials.gov/show/NCT02569320

NCT02177773 Terminated. Reason given: FDA approved agent for this indication during enrollment https://clinicaltrials.gov/show/NCT02177773

NCT04055532 Withdrawn. Reason given: Lack of regulatory approval https://clinicaltrials.gov/show/NCT04055532

NCT02428309 Terminated. Reason given: Due to participant recruitment feasibility https://clinicaltrials.gov/show/NCT02428309

NCT03224559 Withdrawn. Reason given: Enrollment never began. https://clinicaltrials.gov/show/NCT03224559

NCT02187822 Terminated. Reason given: lack of funding by company providing TPI-287 https://clinicaltrials.gov/show/NCT02187822

NCT03477864 Withdrawn. Reason given: Study was not accruing https://clinicaltrials.gov/show/NCT03477864

NCT03290092 Terminated. Reason given: In accordance with the protocol, following the occurrence of two SUSARs, the TOTEM trial was stopped early for safety reasons. https://clinicaltrials.gov/show/NCT03290092

NCT03479034 Withdrawn. Reason given: Investigator decided not to proceed in Australia at this stage. https://clinicaltrials.gov/show/NCT03479034

NCT02730715 Suspended. Reason given: Re-evaluation of amount of T Cell collection needed. https://clinicaltrials.gov/show/NCT02730715

NCT02192489 Withdrawn. Reason given: Administrative https://clinicaltrials.gov/show/NCT02192489

NCT02314598 Terminated. Reason given: No chance to meet the foreseen target of patients with study endpoint https://clinicaltrials.gov/show/NCT02314598

NCT02735551 Terminated. Reason given: Inadequate participant enrollment during recruitment period. https://clinicaltrials.gov/show/NCT02735551

NCT02716896 Terminated. Reason given: Study ended due to lack of eligible subjects and funding not renewing https://clinicaltrials.gov/show/NCT02716896

NCT00673439 Terminated. Reason given: study terminated due to low accrual https://clinicaltrials.gov/show/NCT00673439

NCT02497612 Terminated. Reason given: All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped. https://clinicaltrials.gov/show/NCT02497612

NCT03250689 Terminated. Reason given: Study terminated due to a change in the benefit-risk profile for danirixin in COPD. https://clinicaltrials.gov/show/NCT03250689